TIRZEPATIDE Product Specifications:

Tirzepatide, a synthetic peptide, blends features of two hormones. Scientists craft it with 39 amino acids, incorporating a C20 fatty diacid. Consequently, this addition enhances its stability. Moreover, its structure mimics both GLP-1 and GIP hormones. Thus, tirzepatide fascinates researchers in peptide science.

The peptide binds to GLP-1 and GIP receptors, showing dual affinity. Furthermore, it resists quick breakdown in the body. As a result, scientists study its durability. Additionally, its production involves complex chemical synthesis. Hence, researchers explore its manufacturing techniques.

Tirzepatide’s creation by Eli Lilly marks a scientific leap. Initially, researchers designed it in the 2010s for experimental studies. Subsequently, its name reflects its unique molecular design. Moreover, it captures attention in global labs. Therefore, it drives innovative biochemical research.

In studies, tirzepatide circulates effectively in biological systems. Furthermore, it maintains stability under various conditions. Consequently, scientists investigate its pharmacokinetic traits. Additionally, labs worldwide analyze its molecular structure. Thus, tirzepatide fuels advancements in peptide science, inspiring further exploration and discovery.

• Appearance:Solid white powder in 3ml glass vial
• Chemical Formula:C225H348N48O68
• PubChem CID:58651
• CAS Number:2023788-19-2
• Molecular Weight:4813.527 g/mol
• Storage:Store in a cool, dry place away from light, heat and moisture
• Synonyms:MOUNJARO, LY-3298176, LY3298176
• Sequence:Not provided
• Concentration:≥98%